{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-061835","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.878840+00:00","generated_at":"2026-05-18T22:52:49.463566+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Liquidia receives $50M from HCR after first commercial YUTREPIA sale and court win","bullets":["Received $50M from HCR after court denied preliminary injunction and first commercial sale of YUTREPIA.","Total funding under HCR agreement now $175M of $200M potential; $25M more available if net sales exceed $100M by June 30, 2026.","Payments to HCR capped at 175% of amounts funded; true-up due if IRR falls below 13% for this $50M tranche.","CFO says proceeds will accelerate launch execution, clinical pipeline, and manufacturing build-out."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-061835","json":"https://secwatch.observer/filing/0001104659-25-061835.json","markdown":"https://secwatch.observer/filing/0001104659-25-061835.md","text":"https://secwatch.observer/filing/0001104659-25-061835.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925061835/0001104659-25-061835-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925061835/tm2518664d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:52:49.463566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}